Vanderbilt University
Novel defibrillation lead beats safety, efficacy goals
A novel lead for use in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators exceeded the safety and efficacy thresholds in the LEADR trial, researchers reported at Heart Rhythm 2024.
Patient advocacy reporting system may reduce cost of orthopedic malpractice claims
Adoption and implementation of a patient advocacy reporting program was associated with a significant decrease in the cost of malpractice claims for high-risk clinicians in an orthopedic practice network, according to published results.
Extended oral antibiotic prophylaxis may not reduce risk of PJI after TJA
Published results showed extended oral antibiotic prophylaxis was not associated with a reduced risk of periprosthetic joint infection at 90 days or 1 year among patients who underwent total hip or total knee arthroplasty.
Bariatric surgery tied to improved cardiometabolic health, lower CVD risk
Adults with obesity who underwent bariatric surgery had improvements in multiple cardiometabolic measures after surgery, according to findings published in the Journal of the Endocrine Society.
Insights into adverse effects may help guide prostate cancer treatment decision-making
Adverse events experienced by men with prostate cancer varied considerably based on the treatment they received, results of a 10-year follow-up study showed.
Education, workplace culture key to addressing oncology nursing shortage
By 2030, all members of the Baby Boom generation will be aged 65 years or older.
Snacking on tree nuts may reduce risk for metabolic syndrome in young adults
Young adults who consumed tree nuts as snacks had a lower risk for metabolic syndrome than those who did not, as well as improvements in waist circumference, visceral fat and blood insulin levels, a study found.
Haploidentical bone marrow transplant provides ‘higher access’ to sickle cell disease cure
Reduced-intensity haploidentical-bone marrow transplant showed durable donor engraftment at 2-years follow-up with low mortality among adults with severe sickle cell disease, according to study results.
Low-salt diet confers similar BP benefit to common first-line antihypertensive medication
PHILADELPHIA — Switching to a low-sodium diet conferred BP benefits similar to that of hydrochlorothiazide, a common first-line antihypertensive medication, a speaker reported.
Deep venous arterialization continues to benefit patients with severe CLTI at 12 months
Most patients with severe chronic limb-threatening ischemia treated with a transcatheter deep venous arterialization system achieved limb salvage at 12 months, according to new data from the PROMISE II trial.